61 related articles for article (PubMed ID: 11425274)
1. Suppression of tubulin tyrosine ligase activity through reversible phosphorylation: a mechanism for inhibition of alpha-tubulin tyrosinylation.
Idriss HT
Med Hypotheses; 2001 Feb; 56(2):129-133. PubMed ID: 11425274
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of tubulin tyrosine ligase: a potential mechanism for regulation of alpha-tubulin tyrosination.
Idriss HT
Cell Motil Cytoskeleton; 2000 May; 46(1):1-5. PubMed ID: 10842328
[TBL] [Abstract][Full Text] [Related]
3. A vital role of tubulin-tyrosine-ligase for neuronal organization.
Erck C; Peris L; Andrieux A; Meissirel C; Gruber AD; Vernet M; Schweitzer A; Saoudi Y; Pointu H; Bosc C; Salin PA; Job D; Wehland J
Proc Natl Acad Sci U S A; 2005 May; 102(22):7853-8. PubMed ID: 15899979
[TBL] [Abstract][Full Text] [Related]
4. Parthenolide inhibits tubulin carboxypeptidase activity.
Fonrose X; Ausseil F; Soleilhac E; Masson V; David B; Pouny I; Cintrat JC; Rousseau B; Barette C; Massiot G; Lafanechère L
Cancer Res; 2007 Apr; 67(7):3371-8. PubMed ID: 17409447
[TBL] [Abstract][Full Text] [Related]
5. Posttranslational nitrotyrosination of alpha-tubulin induces cell cycle arrest and inhibits proliferation of vascular smooth muscle cells.
Phung AD; Soucek K; Kubala L; Harper RW; Chloë Bulinski J; Eiserich JP
Eur J Cell Biol; 2006 Dec; 85(12):1241-52. PubMed ID: 17118269
[TBL] [Abstract][Full Text] [Related]
6. Three steps to cancer: how phosphorylation of tubulin, tubulin tyrosine ligase and P-glycoprotein may generate and sustain cancer.
Idriss HT
Cancer Chemother Pharmacol; 2004 Aug; 54(2):101-4. PubMed ID: 15118838
[TBL] [Abstract][Full Text] [Related]
7. Suppression of tubulin tyrosine ligase during tumor growth.
Lafanechère L; Courtay-Cahen C; Kawakami T; Jacrot M; Rüdiger M; Wehland J; Job D; Margolis RL
J Cell Sci; 1998 Jan; 111 ( Pt 2)():171-81. PubMed ID: 9405300
[TBL] [Abstract][Full Text] [Related]
8. Microtubule-associated protein 1B interaction with tubulin tyrosine ligase contributes to the control of microtubule tyrosination.
Utreras E; Jiménez-Mateos EM; Contreras-Vallejos E; Tortosa E; Pérez M; Rojas S; Saragoni L; Maccioni RB; Avila J; González-Billault C
Dev Neurosci; 2008; 30(1-3):200-10. PubMed ID: 18075266
[TBL] [Abstract][Full Text] [Related]
9. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity.
Banan A; Fields JZ; Zhang LJ; Shaikh M; Farhadi A; Keshavarzian A
J Pharmacol Exp Ther; 2003 Oct; 307(1):53-66. PubMed ID: 12893839
[TBL] [Abstract][Full Text] [Related]
10. Recombinant mammalian tubulin polyglutamylase TTLL7 performs both initiation and elongation of polyglutamylation on beta-tubulin through a random sequential pathway.
Mukai M; Ikegami K; Sugiura Y; Takeshita K; Nakagawa A; Setou M
Biochemistry; 2009 Feb; 48(5):1084-93. PubMed ID: 19152315
[TBL] [Abstract][Full Text] [Related]
11. Post-translational modifications of tubulin in the nervous system.
Fukushima N; Furuta D; Hidaka Y; Moriyama R; Tsujiuchi T
J Neurochem; 2009 May; 109(3):683-93. PubMed ID: 19250341
[TBL] [Abstract][Full Text] [Related]
12. Sesterterpenes as tubulin tyrosine ligase inhibitors. First insight of structure-activity relationships and discovery of new lead.
Dal Piaz F; Vassallo A; Lepore L; Tosco A; Bader A; De Tommasi N
J Med Chem; 2009 Jun; 52(12):3814-28. PubMed ID: 19459643
[TBL] [Abstract][Full Text] [Related]
13. Normal and prostate cancer cells display distinct molecular profiles of alpha-tubulin posttranslational modifications.
Soucek K; Kamaid A; Phung AD; Kubala L; Bulinski JC; Harper RW; Eiserich JP
Prostate; 2006 Jun; 66(9):954-65. PubMed ID: 16541425
[TBL] [Abstract][Full Text] [Related]
14. Tubulin-tyrosine ligase, a long-lasting enigma.
Erck C; Frank R; Wehland J
Neurochem Res; 2000 Jan; 25(1):5-10. PubMed ID: 10685598
[TBL] [Abstract][Full Text] [Related]
15. The role of α-tubulin tyrosination in controlling the structure and function of hippocampal neurons.
Hosseini S; van Ham M; Erck C; Korte M; Michaelsen-Preusse K
Front Mol Neurosci; 2022; 15():931859. PubMed ID: 36340693
[TBL] [Abstract][Full Text] [Related]
16. Interaction of maize (Zea mays) protein phosphatase 2A with tubulin.
Awotunde OS; Lechward K; Krajewska K; Zołnierowicz S; Muszyńska G
Acta Biochim Pol; 2003; 50(1):131-8. PubMed ID: 12673353
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
[TBL] [Abstract][Full Text] [Related]
18. The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity.
Zhang LH; Wu L; Raymon HK; Chen RS; Corral L; Shirley MA; Narla RK; Gamez J; Muller GW; Stirling DI; Bartlett JB; Schafer PH; Payvandi F
Cancer Res; 2006 Jan; 66(2):951-9. PubMed ID: 16424030
[TBL] [Abstract][Full Text] [Related]
19. The testis-specific apoptosis related gene TTL.6 underwent adaptive evolution in the lineage leading to humans.
Chen XH; Shi H; Liu XL; Su B
Gene; 2006 Mar; 370():58-63. PubMed ID: 16443334
[TBL] [Abstract][Full Text] [Related]
20. Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis.
Mialhe A; Lafanechère L; Treilleux I; Peloux N; Dumontet C; Brémond A; Panh MH; Payan R; Wehland J; Margolis RL; Job D
Cancer Res; 2001 Jul; 61(13):5024-7. PubMed ID: 11431336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
